Alex Tarrabain - 25 Jun 2021 Form 4 Insider Report for CEN BIOTECH INC

Role
Chief Financial Officer, Director
Signature
/s/ Alex Tarrabain
Issuer symbol
N/A
Transactions as of
25 Jun 2021
Net transactions value
$0
Form type
4
Filing time
25 Jun 2021, 17:04:05 UTC
Previous filing
03 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CENBF Common Stock Award $0 +1,000,000 +56% $0.000000 2,775,942 25 Jun 2021 Direct F1
transaction CENBF Common Stock Other $0 +3,000 +0.11% $0.000000 2,775,942 16 Jun 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1,000,000 shares of common stock of the issuer were granted by the issuer on June 25, 2021, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
F2 3,000 shares of common stock of the issuer were issued to the reporting person on June 16, 2021, as consideration for extending the maturity date of a promissory note dated January 14, 2018.